Participations à des congrès et colloques internationaux (33)
5.
Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Identification of let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies. Abstract session presented at fTALES Meeting(2019-09-18: Ghent)6.
Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Identification of let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies. Poster présenté à la conférence fTALES Meeting (18/9/2019: Ghent).7.
Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Identification of let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies: Flash oral presentation. Abstract session presented at EDT –CANCEROLOGY(06/09/2019: Brussels, Belgium)8.
Alexandri, C., Stamatopoulos, B., Bareche, Y., Jabin, I., Bruylants, G., & Demeestere, I. (2019). Let-7a as a target to prevent chemotherapy-induced ovarian damage in mouse model: a novel & non-invasive pharmacological approach in future fertility preservation strategies. Poster présenté à la conférence EDT - Cancerology Annual Meeting (UCL) (06-09-2019: Brussels).9.
Alexandri, C., Stamatopoulos, B., Rothé, F., Devos, M., Retout, M., Daniel, A., Grosbois, J., & Demeestere, I. (2019). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. Abstract session presented at Journée des doctorants(19: 25/04/2019: Faculté médecine, ULB)10.
Alexandri, C., Stamatopoulos, B., Rothé, F., Devos, M., Retout, M., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy-induced ovarian damage using mice model. Poster présenté à la conférence Congress Drug Development (03-05/12/2018: San Francisco, USA).